April 5, 2018 / 12:11 PM / 18 days ago

BRIEF-Aradigm Announces EMA Has Completed Its Validation Of The MAA Submission

Reuters Staff

1 Min Read

April 5 (Reuters) - Aradigm Corp:

* ARADIGM ANNOUNCES THE EMA HAS COMPLETED ITS VALIDATION OF THE MAA SUBMISSION

* OPINION OF COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) FOR LINHALIQ EXPECTED WITHIN 210 DAYS Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.